Is there any useful surrogate to evaluate metabolic fatty liver disease?

J Chin Med Assoc. 2021 Apr 1;84(4):344-345. doi: 10.1097/JCMA.0000000000000512.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers*
  • Humans
  • Interleukin-2 / metabolism
  • Metabolic Syndrome
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / physiopathology*

Substances

  • Biomarkers
  • Interleukin-2